Glucagon Like Peptide 1 Based Therapies: A New Horizon in Obesity Management Beyond semaglutide and tirzepatide, where might we find the next GLP 1 based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP1, GIP, and Glucagon Agonists Khan 2026 Journal of Peptide Science Wiley Online Library With the release of the World Health Organization's guideline on GLP 1 medications for obesity management, policymakers and clinicians are increasingly asking what global eligibility for these therapies looks like in practice. Co authored What is the pipeline for future medications for obesity? International Journal of Obesity Tirzepatide Dosage Chart & Dosing Guide for Weight Loss